Tokyo, Sept. 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059021) titled 'Identification of genetic variants associated with chronic idiopathic intestinal pseudo-obstruction and development of blood screening test' on Sept. 6.
Study Type:
Observational
Primary Sponsor:
Institute - Fujita Health University School of Medicine
Condition:
Condition - chronic idiopathic intestinal pseudo-obstruction
Classification by malignancy - Others
Genomic information - YES
Objective:
Narrative objectives1 - Patients with chronic idiopathic intestinal pseudo-obstruction may develop at a young age and familial onset, therefore, genetic factors are strongly suspected to be associated with its pathogenesis. In addition, a delay in diagnosis from onset to diagnosis has been noted, and blood biomarkers will be explored.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients with established or suspected chronic idiopathic intestinal pseudo-obstruction
Key exclusion criteria - Patients with chronic secondary intestinal pseudo-obstruction
Target Size - 50
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2025 Year 09 Month 06 Day
Date of IRB - 2022 Year 07 Month 21 Day
Anticipated trial start date - 2025 Year 09 Month 06 Day
Last follow-up date - 2028 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067500
Disclaimer: Curated by HT Syndication.
